JAZZ
#675
Jazz Pharmaceuticals plc - Ordinary Shares
251.1 0 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.73%
Monthly Change
-2.39%
6 month change
+32.69%
Year Change
+79.36%
Previous Close
249.2 9
Open
251.1 0
Low
251.1 0
High
251.1 0
Volume
105
Financials
- Market Capitalization 16.3 B
- Employee 2 890
- Founded 2003
- CEO Bruce C Cozadd
- Website www.jazzpharmaceuticals.com
- Headquarter Ireland
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-29.11
Price to sales ratio
2.43
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 511 |  INCY Incyte Corporation - Common Stock | 127.74 USD | -0.30% | +0.79% | -0.88% | +52.34% | 25.89 B USD | ||
| 564 |  UTHR United Therapeutics Corporation - Common Stock | 527.91 USD | +2.17% | +0.89% | +0.35% | +71.87% | 22.64 B USD | ||
| 696 |  ASND Ascendis Pharma A/S - American Depositary Shares | 249.36 USD | -0.36% | -2.48% | -2.19% | +21.59% | 15.45 B USD | ||
| 700 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 78.68 USD | -0.87% | -5.08% | -7.02% | +38.04% | 15.38 B USD |
Frequently asked questions about Jazz Pharmaceuticals, Inc.
What is the Jazz Pharmaceuticals, Inc. stock price today?
The current price of Jazz Pharmaceuticals, Inc. (JAZZ) is 251.1. Over the past 24 hours, the stock has changed by +0.73%. Follow the JAZZ chart for real-time price dynamics.
What is the stock ticker of Jazz Pharmaceuticals, Inc.?
Jazz Pharmaceuticals, Inc. trades under the ticker JAZZ. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Jazz Pharmaceuticals, Inc. stock going up?
JAZZ has changed by +0.94% over the last week, -2.39% over the last month, and +79.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Jazz Pharmaceuticals, Inc.?
Jazz Pharmaceuticals, Inc. currently has a market capitalization of 16.3 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Jazz Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Jazz Pharmaceuticals, Inc. reported earnings of 3.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Jazz Pharmaceuticals, Inc. revenue for the last quarter?
Jazz Pharmaceuticals, Inc. reported quarterly revenue of 1.21 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Jazz Pharmaceuticals, Inc. net income for the last quarter?
Jazz Pharmaceuticals, Inc. reported net income of 192.8 M for the last quarter. The previous quarter showed 293.1 M, which means net income changed by -34.22%.
How many employees does Jazz Pharmaceuticals, Inc. have?
As of the latest available data, Jazz Pharmaceuticals, Inc. has 2 890 employees. Workforce size can provide additional context about the company's scale and operations.
What is Jazz Pharmaceuticals, Inc. EBITDA?
Jazz Pharmaceuticals, Inc. EBITDA is 427.3 M, and its EBITDA margin is 35.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Jazz Pharmaceuticals, Inc. stock?
You can buy Jazz Pharmaceuticals, Inc. (JAZZ) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Jazz Pharmaceuticals, Inc. stock?
Investing in Jazz Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JAZZ chart and related analysis on metatrader.com as part of your research.